# ERYTHROMYCIN
> **ANDA219691** · Abbreviated New Drug Application (Generic) · Sponsor: ABON PHARMS LLC · Approved 2025-09-23
## Drug
- **FDA Application Number:** ANDA219691
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERYTHROMYCIN
- **Generic name:** Erythromycin
- **Active ingredients:** ERYTHROMYCIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABON PHARMS LLC
- **First approval:** 2025-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219691)
---
*AI Analytics · CC0 1.0*